Added to YB: 2024-04-04
Pitch date: 2024-04-02
ROIV [bullish]
Roivant Sciences Ltd.
+102.38%
current return
Author Info
Raging Bull Investments is a lawyer by background who shares actionable investment ideas on value opportunities with a catalyst. Sign up for the newsletter.
Company Info
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
Market Cap
$14.1B
Pitch Price
$10.92
Price Target
20.00 (-10%)
Dividend
N/A
EV/EBITDA
-9.39
P/E
-20.20
EV/Sales
505.07
Sector
Biotechnology
Category
special_situation
Raging Bull Investments' Favorite Position Heading into Q2: Roivant Sciences Ltd.
ROIV: Trades near cash+IMVT stake value, getting pipeline for free. Catalysts: Vtama expansion, 8 P2/3 trials, LNP litigation. $1.5B buyback at $9.10 clears overhang. Brepocitinib P2 win in large NIU market. $20 PT on buybacks + pipeline readouts.
Read full article (3 min)